BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1377547)

  • 1. Intradermal angiogenesis in nude mice induced by human tumor cells or b-FGF.
    Weckbecker G; Liu R; Tolcsvai L
    EXS; 1992; 61():296-301. PubMed ID: 1377547
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis.
    Shimo T; Nakanishi T; Nishida T; Asano M; Sasaki A; Kanyama M; Kuboki T; Matsumura T; Takigawa M
    Oncology; 2001; 61(4):315-22. PubMed ID: 11721179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin.
    Leith JT; Papa G; Quaranto L; Michelson S
    Br J Cancer; 1992 Aug; 66(2):345-8. PubMed ID: 1503909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma.
    Cheng WF; Lee CN; Chu JS; Chen CA; Chen TM; Shau WY; Hsieh CY; Hsieh FJ
    Cancer; 1999 Feb; 85(3):651-7. PubMed ID: 10091738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined morphological approaches in the study of network formation in tumor angiogenesis.
    Konerding MA; van Ackern C; Steinberg F; Streffer C
    EXS; 1992; 61():40-58. PubMed ID: 1377562
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxygen tension in human squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Lyng H; Sundfør K; Rofstad EK
    Adv Exp Med Biol; 1998; 454():635-41. PubMed ID: 9889944
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of two methods to assess tumour vasculature in human cervical carcinoma.
    Davidson SE; Moore JV; West CM; Hunter RD
    Int J Radiat Biol; 1991; 60(1-2):169-73. PubMed ID: 1677965
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer.
    Höckel S; Schlenger K; Vaupel P; Höckel M
    Int J Oncol; 2001 Oct; 19(4):827-32. PubMed ID: 11562762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis in squamous cell carcinoma in situ and microinvasive carcinoma of the uterine cervix.
    Smith-McCune K
    Obstet Gynecol; 1997 Mar; 89(3):482-3. PubMed ID: 9052610
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.
    Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Zuna I; Knof A; Brix G; Schaeffer U; Wilkens C; Schoenberg SO; Essig M; Vaupel P; van Kaick G
    Cancer Res; 1997 Nov; 57(21):4777-86. PubMed ID: 9354439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different angiogenic pathways in human cervical cancers.
    Tokumo K; Kodama J; Seki N; Nakanishi Y; Miyagi Y; Kamimura S; Yoshinouchi M; Okuda H; Kudo T
    Gynecol Oncol; 1998 Jan; 68(1):38-44. PubMed ID: 9454658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of blood flow in uterine vessels by Doppler-metry in patients with cervical cancer].
    Meshkova IE; Katamadze IG; Semenov II
    Vopr Onkol; 2004; 50(4):444-8. PubMed ID: 15605769
    [No Abstract]   [Full Text] [Related]  

  • 13. CD34 as a marker for evaluating angiogenesis in cervical cancer.
    Vieira SC; Silva BB; Pinto GA; Vassallo J; Moraes NG; Santana JO; Santos LG; Carvasan GA; Zeferino LC
    Pathol Res Pract; 2005; 201(4):313-8. PubMed ID: 15991838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
    Czubayko F; Liaudet-Coopman ED; Aigner A; Tuveson AT; Berchem GJ; Wellstein A
    Nat Med; 1997 Oct; 3(10):1137-40. PubMed ID: 9334727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate.
    Wellstein A; Zugmaier G; Califano JA; Kern F; Paik S; Lippman ME
    J Natl Cancer Inst; 1991 May; 83(10):716-20. PubMed ID: 1708834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eldecalcitol (ED-71), an analog of 1α,25(OH)
    Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
    In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer.
    Zhou X; Xu CJ; Wang JX; Dai T; Ye YP; Cui YM; Liao WT; Wu XL; Ou JP
    Int J Gynecol Cancer; 2015 Oct; 25(8):1353-63. PubMed ID: 26332389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors.
    Czubayko F; Smith RV; Chung HC; Wellstein A
    J Biol Chem; 1994 Nov; 269(45):28243-8. PubMed ID: 7525570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of angiogenesis inhibitors by modified tumor-induced angiogenesis (TIA) test in lung cancer.
    Skopińska-Rózewska E; Sommer E; Demkow U; Chorostowska-Wynimko J; Bałan B; Rózycka B; Barcz E; Filewska M; Mlekodaj S; Rudziński P; Seweryniak W; Caban P; Kupis W; Bogdan J; Usiekniewicz P; Gatarek J; Langfort R
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():287-96. PubMed ID: 9337546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.